Frequency of bap and cpaA virulence genes in drug resistant clinical isolates of Acinetobacter baumannii and their role in biofilm formation

سال انتشار: 1396
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 289

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-20-8_002

تاریخ نمایه سازی: 28 مهر 1400

چکیده مقاله:

Objective(s): Acinetobacter baumannii has a high propensity to form biofilm and frequently causes medical device-related infections with multiple-drug-resistance in hospitals. The aim of this work is to study antimicrobial resistance and the role of bap and cpaA genes in biofilm formation by A. baumannii to understand how this pathogen persists in the hospital environment. Materials and Methods: Theantibiotic resistance profile and in vitro biofilm-forming ability of one hundred clinical isolates of A. baumannii was evaluated by disc diffusion and crystal-violet staining methods, respectively. Isolates were tested for the presence of bap and cpaA genes. Results: The isolates were highly resistant to cefepime, third-generation cephalosporins, ciprofloxacin, cotrimoxazole, aminoglycosides and carbapenems. Moreover, four isolates were resistant to colistin. Quantification of biofilm showed that ۴۳% of the isolates were strong biofilm-producer. Furthermore, ۳۲% of the isolates exhibited moderate biofilm-formation and showed initial binding activity. Frequency of bap and cpaA were determined ۹۲% and ۳۶%, respectively. Conclusion: There was strong association between the presence of bap gene and biofilm formation by A. baumannii isolates (P=۰.۰۰۳). In addition, multidrug resistant isolates produced stronger biofilm than other isolates (P=۰.۰۰۰۱). These results indicate importance of biofilm in resistance of isolates and effect of presence of bap gene in biofilm formation by A. baumannii strains.

نویسندگان

Arezoo Fallah

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Mohammad Ahangarzadeh Rezaee

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Alka Hasani

Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Mohammad Hossein Soroush Barhaghi

Department of Microbiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

Hossein Samadi Kafil

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • ۱.Durante-Mangoni E, Utili R, Zarrilli R. Combination therapy in severe ...
  • ۲.Falagas ME, Bliziotis IA, Siempos II. Attributable mortality of Acinetobacter ...
  • ۳.Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the ...
  • ۴.Singhai M, Malik A, Shahid M, Malik MA, Goyal R. ...
  • ۵.Sutherland IW. The biofilm matrix–an immobilized but dynamic microbial environment. ...
  • ۶.Stoodley P, Sauer K, Davies D, Costerton JW. Biofilms as ...
  • ۷.Patel SJ, Oliveira AP, Zhou JJ, Alba L, Furuya EY, ...
  • ۸.Luo TL, Rickard AH, Srinivasan U, Kaye KS, Foxman B. ...
  • ۹.Lasa I, Penadés JR. Bap: a family of surface proteins ...
  • ۱۰.Latasa C, Solano C, Penadés JR, Lasa I. Biofilm-associated proteins. ...
  • ۱۱.Brossard KA, Campagnari AA. The Acinetobacter baumannii biofilm-associated protein plays ...
  • ۱۲.Loehfelm TW, Luke NR, Campagnari AA. Identification and characterization of ...
  • ۱۳.Leung WS, Chu CM, Tsang KY, Lo FH, Lo KF, ...
  • ۱۴.Soares AJ, Santos M, Trugilho M, Neves-Ferreira A, Perales J, ...
  • ۱۵.Delvaeye M, Conway EM. Coagulation and innate immune responses: can ...
  • ۱۶.Massberg S, Grahl L, von Bruehl M-L, Manukyan D, Pfeiler ...
  • ۱۷.Tilley D, Law R, Warren S, Samis JA, Kumar A. ...
  • ۱۸.MacFaddin JF. Biochemical tests for identification of medical bacteria, ۳rd ...
  • ۱۹.Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, ...
  • ۲۰.Pajand O, Ahangarzadeh Rezaee M, Nahaei MR, Mahdian R, Aghazadeh ...
  • ۲۱.Clinical Laboratory Standards Institute, M۱۰۰-S۲۴: Performance Standards for Antimicrobial Susceptibility ...
  • ۲۲.Ahangarzadeh Rezaee M, Abdinia B. Etiology and antimicrobial susceptibility pattern ...
  • ۲۳.Kafil HS, Mobarez AM, Moghadam M, Hashemi Z, MY. Gentamicin ...
  • ۲۴.Kafil HS, Mobarez AM. Assessment of biofilm formation by enterococci ...
  • ۲۵.Akers KS, Mende K, Cheatle KA, Zera WC, Yu X, ...
  • ۲۶.Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of ...
  • ۲۷.Bergogne-Berezin E, Towner K. Acinetobacter spp. as nosocomial pathogens: microbiological, ...
  • ۲۸.Bialvaei AZ, Samadi Kafil H. Colistin, mechanisms and prevalence of ...
  • ۲۹.Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care ...
  • ۳۰.Soroush S, Haghi-Ashtiani MT, Taheri-Kalani M, Emaneini M, Aligholi M, ...
  • ۳۱.Sohrabi N, Farajnia S, Akhi MT, Nahaei MR, Naghili B, ...
  • ۳۲.Ghasemian R, Ahanjan M, Fatehi E, Shokri M. Prevalence and ...
  • ۳۳.Mohajeri P, Farahani A, Feizabadi MM, Ketabi H, Abiri R, ...
  • ۳۴.Azizi O, Shakibaie MR, Modarresi F, Shahcheraghi F. Molecular detection ...
  • ۳۵.Lee HW, Koh Y, Kim J, Lee JC, Lee YC, ...
  • ۳۶.Rodriguez-Bano J, Marti S, Soto S, Fernández-Cuenca F, Cisneros JM, ...
  • ۳۷.Sánchez CJ, Mende K, Beckius ML, Akers KS, Romano DR, ...
  • ۳۸.Cucarella C, Solano C, Valle J, Amorena B, Lasa Í, ...
  • ۳۹.Lasa I. Towards the identification of the common features of ...
  • ۴۰.Badmasti F, Siadat SD, Bouzari S, Ajdary S, Shahcheraghi F. ...
  • ۴۱.Goh HS, Beatson SA, Totsika M, Moriel DG, Phan M-D, ...
  • نمایش کامل مراجع